Edward T. Mathers - Jun 8, 2022 Form 3 Insider Report for Senti Biosciences, Inc.\ (SNTI)

Role
Director
Signature
/s/ Louis Citron, attorney-in-fact
Stock symbol
SNTI
Transactions as of
Jun 8, 2022
Transactions value $
$0
Form type
3
Date filed
6/15/2022, 07:05 PM
Previous filing
Jun 6, 2022
Next filing
Jun 13, 2022

No securities are beneficially owned.

Remarks:

Effective immediately following the Effective Time as defined in that certain Business Combination Agreement dated as of December 19, 2021, as amended, by and among Senti Sub I, Inc. (f/k/a Senti Biosciences, Inc.), Issuer (f/k/a Dynamics Special Purpose Corp.), and Explore Merger Sub, Inc., the reporting person was elected as a member of the board of directors of the Issuer.